Instrument Inactif

Communiqués Acura Pharmaceuticals, Inc. OTC Bulletin Board

Actions

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

04/06	Acura Pharmaceuticals, Inc. et Acura Pharmaceutical Technologies, Inc. annoncent des changements de direction	CI
26/03	Acura Pharmaceuticals, Inc. annonce la modification de l'accord avec Abuse Deterrent Pharma, LLC	CI

Communiqués

Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K	26/03	PU
Acura Pharmaceuticals : AMENDED, CONSOLIDATED AND RESTATED SECURED PROMISSORY NOTE - Form 8-K	21/12	PU
Acura Pharmaceuticals : New Financial Obligation - Form 8-K	06/12	PU
Acura Pharmaceuticals : Termination of Material Agreement - Form 8-K	16/08/23	PU
Acura Pharmaceuticals : TO LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT - Form 8-K	28/06/23	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	20/03/23	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	22/02/23	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	13/02/23	AQ
ACURA PHARMACEUTICALS, INC : Other Events (form 8-K)	02/02/23	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	20/01/23	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	27/12/22	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	14/11/22	AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K	17/10/22	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	17/10/22	AQ
Acura Pharmaceuticals : NEGOTIABLE PROMISSORY NOTE - Form 8-K	26/09/22	PU
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	26/09/22	AQ
ACURA PHARMACEUTICALS, INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	26/08/22	AQ
Acura Pharmaceuticals : Statement of Changes in Beneficial Ownership - Form 4	05/08/22	PU
Acura Pharmaceuticals : Statement of Changes in Beneficial Ownership - Form 4	05/08/22	PU
Acura Pharmaceuticals : Statement of Changes in Beneficial Ownership - Form 4	05/08/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Acura Pharmaceuticals, Inc. OTC Bulletin Board

Actions

Communiqués

Filtres